Transcriptome Alterations in Liver Metastases of Colorectal Cancer After Acquired Resistance to Cetuximab

Background/Aim: Cetuximab in combination with chemotherapy is recommended as first-line therapy for metastatic colorectal cancer (mCRC) with wild-type RAS. However, drug resistance to cetuximab exists widely in mCRC and reduces the prognosis of patients. Although some genomic alterations have been d...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Genomics Proteomics
Autori principali: LI, ZONGCHENG, CHEN, YULING, REN, WU, HU, SHUOFENG, TAN, ZHAOLI, WANG, YAN, CHEN, YAOWEN, ZHANG, JIAN, WU, JIAQI, LI, TINGTING, XU, JIANMING, YING, XIAOMIN
Natura: Artigo
Lingua:Inglês
Pubblicazione: International Institute of Anticancer Research 2019
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6542644/
https://ncbi.nlm.nih.gov/pubmed/31018951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/cgp.20126
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi